Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase.

Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Abstract Text:

J STOVNER,A ENGSETH,I BRENNHOVD,

Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Publishing Authors By Initials

J STOVNER,A ENGSETH,I BRENNHOVD,

For similar digestive system: gastrointestinal tract: pharynx research abstracts see: digestive system: gastrointestinal tract: pharynx research

PUBMED ID PMID:

MEDLINE DATE:

Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 21

Page Numbers: 147-8

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: Aug

YEAR: 1962

Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Keywords Mesh Terms:

KEYWORDS: Pharynx

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Information

Substance Name: Hyaluronoglucosaminidase

Registry Number: EC 3.2.1.35

Grant and Affiliation Information for Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cancer therapy by intra-arterial methotrexate infusion Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase Related Publications

• Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase.
• [Carcinoma urethrae et penis]
• [Malignant melanoma]
• [Mouth and lip cancer]
• [Palpation relief. An important symptom in breast cancer]
• [Sarcoma of the soft tissue]